We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.77%
5 Year Est. Return
+48.6%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$14.7M
Cap. Flow
+$1.42M
Cap. Flow %
0.53%
Top 10 Hldgs %
38.1%
Holding
71
New
3
Increased
13
Reduced
22
Closed
–

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.93M
2
DNOW icon
DNOW Inc
DNOW
+$661K
3
PFE icon
Pfizer
PFE
+$280K
4
LEG icon
Leggett & Platt
LEG
+$200K
5
DO
Diamond Offshore Drilling
DO
+$95.1K

Top Sells

Rank Stock Value
1
NOV icon
NOV
NOV
+$624K
2
SVU
SUPERVALU Inc.
SVU
+$444K
3
ADP icon
Automatic Data Processing
ADP
+$206K
4
VAR
Varian Medical Systems, Inc.
VAR
+$77.5K
5
INTC icon
Intel
INTC
+$71.8K

Sector Composition

Rank Sector Weight
1 Industrials 25.49%
2 Healthcare 22.38%
3 Energy 20.31%
4 Technology 14.32%
5 Consumer Staples 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCAR icon
1
PACCAR
PCAR
$69.6B
$18.7M 7.07%
447,407
– –
PCP
2
DELISTED
PRECISION CASTPARTS CORP
PCP
$13.8M 5.19%
54,521
-246
-0.4% -$62.9K
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$12.3M 4.62%
165,371
-137
-0.1% -$9.57K
INTC icon
4
Intel
INTC
$466B
$8.78M 3.31%
284,225
-2,620
-0.9% -$71.8K
JNJ icon
5
Johnson & Johnson
JNJ
$635B
$8.49M 3.2%
81,160
+40
+0% +$4.04K
SLB icon
6
SLB Ltd
SLB
$77.8B
$8.46M 3.19%
71,763
– –
EQT icon
7
EQT Corp
EQT
$33.2B
$8.45M 3.19%
145,217
-918
-0.6% -$52.6K
HUB.A
8
DELISTED
HUBBELL INC CL-A
HUB.A
$7.64M 2.88%
61,263
-415
-0.7% -$47.1K
XOM icon
9
ExxonMobil
XOM
$651B
$7.27M 2.74%
72,234
-600
-0.8% -$60.5K
WWD icon
10
Woodward
WWD
$25B
$7.15M 2.7%
142,424
– –
RIG icon
11
Transocean
RIG
$5.92B
$6.92M 2.61%
153,609
+303
+0.2% +$12.9K
COST icon
12
Costco
COST
$415B
$6.9M 2.6%
59,887
+225
+0.4% +$25.8K
FLS icon
13
Flowserve
FLS
$9.25B
$6.65M 2.51%
89,460
– –
HD icon
14
Home Depot
HD
$332B
$6.43M 2.43%
79,438
-885
-1% -$69.8K
NOV icon
15
NOV
NOV
$7.45B
$6.33M 2.39%
76,815
-8,373
-10% -$624K
NVS icon
16
Novartis
NVS
$295B
$5.55M 2.09%
68,445
– –
PEP icon
17
PepsiCo
PEP
$186B
$5.36M 2.02%
60,030
-400
-0.7% -$34.5K
EW icon
18
Edwards Lifesciences
EW
$47.6B
$5.22M 1.97%
364,560
– –
EMR icon
19
Emerson Electric
EMR
$82.9B
$5.12M 1.93%
77,165
-540
-0.7% -$36.3K
AAPL icon
20
Apple
AAPL
$4.89T
$5.11M 1.93%
219,800
– –
DVN icon
21
Devon Energy
DVN
$51.9B
$4.92M 1.86%
62,007
– –
DE icon
22
Deere & Co
DE
$170B
$4.81M 1.81%
53,130
+329
+0.6% +$30.3K
WAT icon
23
Waters Corp
WAT
$36.8B
$4.55M 1.71%
43,532
-440
-1% -$46.3K
AEGN
24
DELISTED
Aegion Corp
AEGN
$4.32M 1.63%
185,462
+400
+0.2% +$9.5K
BRKR icon
25
Bruker
BRKR
$9.2B
$4.29M 1.62%
176,648
+2,322
+1% +$50.4K
1
2 3

Similar funds

CFS
Ceros Financial Services Rockville, Maryland $316M AUM
SVWA
Sound View Wealth Advisors Savannah, Georgia $319M AUM
SAS
Sarbit Advisory Services Winnipeg, Manitoba, Canada $294M AUM 0.68% 1-Year Est. Return
LYV
Live Your Vision West Conshohocken, Pennsylvania $330M AUM 2.28% 1-Year Est. Return
TAT
TD Ameritrade Trust Denver, Colorado $285M AUM 0.17% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return
OAMU
Ostrum Asset Management US New York $359M AUM
TCM
Tradition Capital Management Summit, New Jersey $369M AUM 6.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's Q2 2014 Portfolio in Review

As of Q2 2014, Thompson Rubinstein Investment Management held 71 positions worth $265M, up 5.9% from $250M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 4.2%. Thompson Rubinstein Investment Management opened 3 new positions and made no exits, leaving the 71-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Energy.

  • Thompson Rubinstein Investment Management's largest Q2 2014 buy was AbbVie: 36,831 shares worth $2.08M.
  • Thompson Rubinstein Investment Management added most to Pfizer in Q2 2014, an estimated $280K increase.
  • Thompson Rubinstein Investment Management's biggest Q2 2014 reduction was NOV, cutting an estimated $624K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 38% of its $265M portfolio in Q2 2014.
  • Thompson Rubinstein Investment Management opened 3 new positions and closed 0 in Q2 2014.
  • Thompson Rubinstein Investment Management's portfolio value rose 5.9% quarter-over-quarter to $265M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q2 2014, filed 10 Jul 2014.